Fortress Biotech, Inc. (FBIOP) vs Korsana Biosciences, Inc. (KRSA)

A side-by-side comparison of Fortress Biotech, Inc. and Korsana Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — FBIOP vs KRSA

growth of $100 · dividends reinvested · last 8y
FBIOP +73.9% (+7.2%/yr)KRSA -98.2% (-39.7%/yr)FBIOP compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$174$2
FBIOP KRSA

FBIOP vs KRSA: by the numbers

  • •KRSA is the larger company ($144M vs $140M market cap).
  • •FBIOP is profitable (163.32% net margin) while KRSA runs a net loss (-353.00%).
  • •FBIOP grew revenue faster over the past five years (5.39% vs -11.98% CAGR).

Metrics side by side

Valuation

MetricFBIOPKRSA
P/E ratio6.62N/A
Forward P/E6.96N/A
P/S ratio2.0475.93
P/B ratio0.8528.36
FCF yield90.06%N/A

Profitability

MetricFBIOPKRSA
Gross margin62.53%100.00%
Operating margin-111.00%-239.78%
Net margin163.32%-353.00%
ROE68.12%-131.85%
ROIC-10.85%-134.15%

Growth (annualized)

MetricFBIOPKRSA
Revenue CAGR (5Y)5.39%-11.98%
Total return CAGR (5Y)0.05%-40.41%

Frequently asked

Which has grown faster, FBIOP or KRSA?
Over the past five years, FBIOP grew revenue faster — FBIOP at a 5.39% CAGR versus KRSA at -11.98%.
Is FBIOP or KRSA more profitable?
FBIOP runs the higher net margin — FBIOP at 163.32% versus KRSA at -353.00%.
How have FBIOP and KRSA total returns compared?
Over the past 5 years, FBIOP delivered 0.05% and KRSA delivered -40.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.